Open AccessAntibody-based therapies for COVID-19: Can Europe move faster?
Author(s) -
Michel D. Kazatchkine,
Michel Goldman,
JeanLouis Vincent
Publication year - 2020
Publication title -
plos medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.847
H-Index - 228
eISSN - 1549-1676
pISSN - 1549-1277
DOI - 10.1371/journal.pmed.1003127
Subject(s) - medicine , context (archaeology) , immunology , antibody , european union , immunity , vaccination , convalescent plasma , virology , intensive care medicine , immune system , covid-19 , disease , infectious disease (medical specialty) , biology , paleontology , business , economic policy
Michel Goldman and colleagues call on the European medical and scientific community to coordinate efforts on immunotherapy-based approaches to coronavirus.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom